Von Hoff DD - Search Results

1

Preclinical activity of ilmofosine against human tumor colony forming units in vitro.

Hanauske AR, Degen D, Marshall MH, Hilsenbeck SG, McPhillips JJ, Von Hoff DD. Hanauske AR, et al. Among authors: von hoff dd. Anticancer Drugs. 1992 Feb;3(1):43-6. doi: 10.1097/00001813-199202000-00008. Anticancer Drugs. 1992. PMID: 1623215

2

Adenocarcinoma of unknown primary: retrospective analysis of chemosensitivity of 313 freshly explanted tumors in a tumor cloning system.

Hanauske AR, Clark GM, Von Hoff DD. Hanauske AR, et al. Among authors: von hoff dd. Invest New Drugs. 1995;13(1):43-9. doi: 10.1007/BF02614219. Invest New Drugs. 1995. PMID: 7499107

3

Activity of CPT-11 (irinotecan hydrochloride), a topoisomerase I inhibitor, against human tumor colony-forming units.

Shimada Y, Rothenberg M, Hilsenbeck SG, Burris HA 3rd, Degen D, Von Hoff DD. Shimada Y, et al. Among authors: von hoff dd. Anticancer Drugs. 1994 Apr;5(2):202-6. doi: 10.1097/00001813-199404000-00011. Anticancer Drugs. 1994. PMID: 8049503

4

In vitro activity of the benzotriazine dioxide SR 4233 against human tumour colony-forming units.

Hanauske AR, Ross M, Degen D, Hilsenbeck SG, Von Hoff DD. Hanauske AR, et al. Among authors: von hoff dd. Eur J Cancer. 1993;29A(3):423-5. doi: 10.1016/0959-8049(93)90400-a. Eur J Cancer. 1993. PMID: 8398345

5

Antiproliferative effects of interleukin-12 treatment on human tumor colony-forming units taken directly from patients.

Izquierdo MA, Degen D, Sypek JP, Von Hoff DD. Izquierdo MA, et al. Among authors: von hoff dd. Anticancer Drugs. 1996 May;7(3):275-80. doi: 10.1097/00001813-199605000-00006. Anticancer Drugs. 1996. PMID: 8792000

6

Effects of prolonged versus short-term exposure paclitaxel (Taxol) on human tumor colony-forming units.

Raymond E, Hanauske A, Faivre S, Izbicka E, Clark G, Rowinsky EK, Von Hoff DD. Raymond E, et al. Among authors: von hoff dd. Anticancer Drugs. 1997 Apr;8(4):379-85. doi: 10.1097/00001813-199704000-00011. Anticancer Drugs. 1997. PMID: 9180392

7

Significant activity of a novel cytotoxic agent, LY295501, against a wide range of tumors in the human tumor cloning system.

Diab SG, Hilsenbeck SG, Izbicka E, Weitman SD, Von Hoff DD. Diab SG, et al. Among authors: von hoff dd. Anticancer Drugs. 1999 Mar;10(3):303-7. doi: 10.1097/00001813-199903000-00009. Anticancer Drugs. 1999. PMID: 10327037

8

Effects of Taxotere and taxol on in vitro colony formation of freshly explanted human tumor cells.

Hanauske AR, Degen D, Hilsenbeck SG, Bissery MC, Von Hoff DD. Hanauske AR, et al. Among authors: von hoff dd. Anticancer Drugs. 1992 Apr;3(2):121-4. doi: 10.1097/00001813-199204000-00008. Anticancer Drugs. 1992. PMID: 1356030

9

Lack of effects of recombinant human interleukin-4 on in vitro colony formation of freshly explanted human tumor cells.

Hanauske AR, Degen D, Marshall MH, Trotta PP, Von Hoff DD. Hanauske AR, et al. Among authors: von hoff dd. Invest New Drugs. 1992 Nov;10(4):269-73. doi: 10.1007/BF00944180. Invest New Drugs. 1992. PMID: 1487400

10

Effects of recombinant human interleukin-1 alpha on clonogenic growth of primary human tumors in vitro.

Hanauske AR, Degen D, Marshall MH, Hilsenbeck SG, Banks P, Stuckey J, Leahy M, Von Hoff DD. Hanauske AR, et al. Among authors: von hoff dd. J Immunother (1991). 1992 Apr;11(3):155-8. doi: 10.1097/00002371-199204000-00001. J Immunother (1991). 1992. PMID: 1515420

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

773 results

Search Page

Filters